Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koon Teo

Showing results (101-110 of 171) with videos related to

Pageof 18
Sort By:
Global Heart|October 25, 2016
Secondary CV Prevention in South America in a Community Setting: The PURE StudyAlvaro Avezum, Gustavo B F Oliveira, Fernando Lanas, et al.
Plos One|November 5, 2014
A novel method to evaluate the community built environment using photographs--Environmental Profile of a Community Health (EPOCH) photo neighbourhood evaluation toolClara K Chow, Daniel J Corsi, Karen Lock, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 7, 2009
The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristicsBrett R Cowan, Alistair A Young, Craig Anderson, et al.
The New England Journal of Medicine|November 13, 2020
Polypill with or without Aspirin in Persons without Cardiovascular DiseaseSalim Yusuf, Philip Joseph, Antonio Dans, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|September 2, 2006
Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424Leslee J Shaw, Gary V Heller, Paul Casperson, et al.
The American Journal of Cardiology|November 26, 2009
Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET])Brett R Cowan, Alistair A Young, Craig Anderson, et al.
Plos Medicine|March 21, 2018
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant dataKunal N Karmali, Donald M Lloyd-Jones, Joep van der Leeuw, et al.
The Canadian Journal of Cardiology|July 28, 2014
Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart diseaseG B John Mancini, Gilbert Gosselin, Benjamin Chow, et al.
JACC. Cardiovascular Interventions|January 21, 2014
Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemiaG B John Mancini, Pamela M Hartigan, Leslee J Shaw, et al.
American Heart Journal|June 20, 2006
Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trialWilliam S Weintraub, Paul Barnett, Shuo Chen, et al.
Pageof 18

Showing results (101-110 of 171) with videos related to

Sort By:
Pageof 18
Global Heart|October 25, 2016
Secondary CV Prevention in South America in a Community Setting: The PURE StudyAlvaro Avezum, Gustavo B F Oliveira, Fernando Lanas, et al.
Plos One|November 5, 2014
A novel method to evaluate the community built environment using photographs--Environmental Profile of a Community Health (EPOCH) photo neighbourhood evaluation toolClara K Chow, Daniel J Corsi, Karen Lock, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|April 7, 2009
The cardiac MRI substudy to ongoing telmisartan alone and in combination with ramipril global endpoint trial/telmisartan randomized assessment study in ACE-intolerant subjects with cardiovascular disease: analysis protocol and baseline characteristicsBrett R Cowan, Alistair A Young, Craig Anderson, et al.
The New England Journal of Medicine|November 13, 2020
Polypill with or without Aspirin in Persons without Cardiovascular DiseaseSalim Yusuf, Philip Joseph, Antonio Dans, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|September 2, 2006
Gated myocardial perfusion single photon emission computed tomography in the clinical outcomes utilizing revascularization and aggressive drug evaluation (COURAGE) trial, Veterans Administration Cooperative study no. 424Leslee J Shaw, Gary V Heller, Paul Casperson, et al.
The American Journal of Cardiology|November 26, 2009
Left ventricular mass and volume with telmisartan, ramipril, or combination in patients with previous atherosclerotic events or with diabetes mellitus (from the ONgoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial [ONTARGET])Brett R Cowan, Alistair A Young, Craig Anderson, et al.
Plos Medicine|March 21, 2018
Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: A meta-analysis of individual participant dataKunal N Karmali, Donald M Lloyd-Jones, Joep van der Leeuw, et al.
The Canadian Journal of Cardiology|July 28, 2014
Canadian Cardiovascular Society guidelines for the diagnosis and management of stable ischemic heart diseaseG B John Mancini, Gilbert Gosselin, Benjamin Chow, et al.
JACC. Cardiovascular Interventions|January 21, 2014
Predicting outcome in the COURAGE trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation): coronary anatomy versus ischemiaG B John Mancini, Pamela M Hartigan, Leslee J Shaw, et al.
American Heart Journal|June 20, 2006
Economics methods in the Clinical Outcomes Utilizing percutaneous coronary Revascularization and Aggressive Guideline-driven drug Evaluation (COURAGE) trialWilliam S Weintraub, Paul Barnett, Shuo Chen, et al.
Pageof 18